Merit Medical shareholders approve 2026 equity plan and elect four directors
At its annual meeting on May 13, 2026, Merit Medical shareholders approved the 2026 Equity Incentive Plan and the 2026 Employee Stock Purchase Plan, elected four directors, and ratified Deloitte and Touche LLP as auditor for fiscal 2026. The Board also adopted Fifth Amended and Restated Bylaws effective May 14, 2026. The equity plan reserves a maximum of 2,700,000 shares of common stock for awards, which shareholders should weigh when considering future share issuance.
Key points
- Equity Incentive Plan approved with 48,750,003 votes for and 1,510,844 against; maximum share reserve of 2,700,000 shares
- Four directors elected: Martha G. Aronson, Lonny J. Carpenter and Scott R. Ward to 2029 terms; Lynne N. Ward to a 2027 term
- Say-on-pay advisory vote passed with 48,835,995 for and 1,415,355 against
- Fifth A&R Bylaws, effective May 14, 2026, add remote meeting participation, electronic notice and updated universal proxy provisions
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 19, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.